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Abstract
Background: Gender and enhanced novelty reactivity can predispose certain individuals to drug abuse. Previous
research in male and female rats selectively bred for high or low locomotor reactivity to novelty found that bred
High Responders (bHRs) acquire cocaine self-administration more rapidly than bred Low Responders (bLRs) and
that bHR females in particular self-administered more cocaine than the other groups. The experiments presented
here aimed to determine whether an individual’s sex and behavioral phenotype interact to affect motivation to
take cocaine.
Methods: We examined motivation for taking cocaine in two experiments using a range of doses on a progressive
ratio (PR) schedule of responding in bHR or bLR males and females. Additionally, we included a measure of
continuing to respond in the absence of reinforcement, a feature of addiction that has been recently incorporated
into tests of animal models on the basis of the criteria for substance use disorder in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition. Statistical analyses were performed using PASW Statistics 18.0 software.
Data were analyzed using repeated-measures analysis of variance followed by a Bonferroni correction post hoc test
when applicable.
Results: We found sex differences as well as effects of novelty reactivity on the motivation to self-administer
cocaine. Specifically, females demonstrated higher breaking points on the PR schedule compared with males,
regardless of phenotype, and bHR males and females exhibited higher motivation than bLR animals at a number
of the doses studied.
Conclusions: An individual’s sex continues to be a predisposing factor with respect to drug abuse liability and can
be compounded by additional individual differences such as reactivity to novelty.
Background
Drug abuse vulnerability can vary with an individual’s
sex, hormone status and personality traits (that is,
novelty reactivity), among other factors. In humans, per-
sonality traits such as novelty-seeking, reactivity to
novelty, sensation-seeking and impulsivity contribute to
an enhanced likelihood of substance abuse [1-4]. People
who exhibit a heightened response to novelty use more
drugs compared with those with an attenuated novelty
reactivity response. Thus, novelty responsivity is consid-
ered to be a predictor of drug abuse liability.
Analogously to humans, individual behavioral traits in
rats influence psychostimulant self-administration [5-8].
Indeed, animals that exhibit high novelty-induced loco-
motor behavior (High Responders (HRs)) have increased
sensitivity to the reinforcing effects of drugs compared
with Low Responders (LRs) [7]. Numerous studies have
used the HR-LR model to demonstrate the relationship
between novelty-induced locomotor activity, drug taking
and other risk-taking behaviors [7,9].
A line of rats has been selectively bred on the basis of
their locomotor behavior in a novel, mildly stressful
environment, thus producing bred High Responder
(bHR) and bred Low Responder (bLR) rats [10]. This
selectively bred line of animals shares many characteris-
tics with outbred animals that are commercially
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purchased and subsequently screened and classified to
be HRs or LRs [7,11]. The bHR rats exhibit enhanced
acquisition of cocaine self-administration relative to bLR
rats [5] as well as increased impulsivity (for example,
reduced behavioral inhibition or increased responding
on a task requiring inhibition compared with bLR rats)
[12]. The bHR rats also exhibit an enhanced corticoster-
one response to stress and higher levels of glucocorti-
coid receptor mRNA expression in the hippocampus
relative to bLR rats [13]. The experiments using the
bHR and bLR rat lines demonstrate that the phenotypes
are strongly genetically driven and highly predictable
from one generation to the next [10]. The phenotypic
differences in reactivity to novelty have become more
pronounced and less variable with subsequent genera-
tions of breeding, such that phenotypic classification of
animals can be predicted with >95% certainty. Selective
breeding has also amplified many of the differences seen
in outbred animals and has revealed additional compo-
nents of the phenotype that appear to be significant
with respect to drug abuse liability [12].
An additional factor that puts individuals at increased
risk for drug abuse is whether the individual is female
or male. Women begin using cocaine at earlier ages,
progress through the stages of addiction more quickly,
enter rehabilitation facilities after a shorter period of use
and have shorter periods of abstinence compared with
men [14]. Women also report a stronger dependence on
cocaine and greater cue-induced craving compared with
men [15]. Hormones have been indicated in some of the
effects, as women also report greater pleasure from
smoked cocaine when their estradiol levels are elevated
during their menstrual cycle [16,17].
The preclinical literature supports the idea that there
is a biological basis for, and a hormonal modulation of,
effects of sex and hormones on drug abuse liability.
Female rats demonstrate greater behavioral sensitization
to cocaine after repeated cocaine treatment compared
with males [18,19] and acquire cocaine self-administra-
tion more readily than males [20-24]. Estradiol enhances
the reinforcing effects of cocaine, as female rats work
harder to obtain cocaine during estrus when estradiol is
high or when ovariectomized (OVX) rats are given
estradiol [22,25,26], and they prefer higher doses of
cocaine when in estrus compared with the other phases
of the cycle [27]. Females also work harder on a pro-
gressive ratio (PR) schedule when in estrus or after
estradiol treatment of OVX rats [25,28].
Recent data from our laboratory demonstrated that
bHR male and female rats acquire cocaine self-adminis-
tration behavior significantly faster than bLR male and
female rats and also that bHR female rats ingest greater
amounts of cocaine compared with bHR males as well
as bLR males and females [5]. On the basis of these
findings, we wanted to know whether increased motiva-
tion for the drug was the cause of bHR females’ greater
drug intake. Therefore, the current study sought to
determine the impact of sex and the bHR and bLR
behavioral phenotypes on the motivation to self-admin-
ister cocaine using a PR schedule with a range of doses
of cocaine, with the inclusion of a test to examine the




Adult bHR and bLR male and female Sprague-Dawley
rats (~100 days old) were acquired from the Akil
Laboratory (University of Michigan, Ann Arbor, MI,
USA) in-house breeding colony, where lines are main-
tained. Animals from the 18th and 19th generations
were used for Experiment 1, and animals from the 21st,
23rd and 24th generations were used for Experiment 2.
A description of the breeding strategy and initial beha-
vioral characterization of the bHR and bLR lines was
published previously [10]. Male and female rats were
housed in a 14-hour light:10-hour dark cycle (lights on
at 7:00 AM). Food and water were available ad libitum,
and all experiments were conducted in accordance with
the National Institutes of Health guidelines on labora-
tory animal use and care using a protocol approved by
the University of Michigan Committee on Use and Care
of Animals
Surgical procedures
Approximately 5 days following transfer from the breed-
ing colony room, rats underwent implantation of
indwelling intravenous jugular catheters connected to a
back port. Jugular catheter construction and implanta-
tion were performed using previously described proce-
dures [29]. In short, catheters were constructed by
gluing Silastic tubing (0.51 mm inner diameter ×
0.94 mm outer diameter, Dow Corning, Midland, MI,
USA) to an external guide cannula (22-G guide cannula;
Plastics One, Roanoke, VA, USA) using cranioplastic
cement. A polypropylene mesh was secured to the bot-
tom of the cannula using the same cement. Rats
received an injection of buprenorphine (0.02 mg/kg sub-
cutaneous injection) 30 minutes before they were
anesthetized with isoflurane (5% isoflurane in oxygen).
The free end of the Silastic tubing of the catheter appa-
ratus was inserted into the right jugular vein of the ani-
mal and secured using 4-0 silk sutures around the
tubing and the venous tissue. The catheter port exited
dorsally from the animal. After successful implantation,
the animal’s catheter was flushed with 0.2 mL each of
heparin (30 U/mL in 0.9% sterile saline) and gentamicin
(3 mg/kg) to prevent clotting and infection, respectively.
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A dummy stylet was then inserted into the port open-
ing. Two days after surgery the catheters were flushed
with 0.2 mL of heparin (30 U/mL in 0.9% sterile saline)
and gentamicin (3 mg/kg) and with gentamicin every
day after that. Prior to the beginning of each cocaine
self-administration session, the catheters were flushed
with 0.1 mL of sterile saline and, following the rats’
cocaine self-administration, the catheters were flushed
with gentamicin (3 mg/kg). Female estrous cycle was
monitored via daily vaginal lavage and microscopic
examination of vaginal cells collected immediately fol-
lowing the cocaine self-administration session. Catheter
patency was checked weekly using a solution of Pen-
tothal (thiopental sodium, 15 mg/mL concentration;
range, 0.08 to 0.20 mL) in sterile water.
Cocaine self-administration apparatus
Cocaine self-administration was performed in standard
operant chambers (Med Associates, Inc., Georgia, VT,
USA), during which time animals could poke their
noses (“nose poke”) into the active hole for cocaine or
into an inactive hole, which resulted in no conse-
quences. Rats were connected to the infusion syringe
via a swivel mounted to a counterbalanced arm,
which allowed animals to move freely in the testing
environment.
Experiment 1: cocaine self-administration protocol
Fixed ratio training (week 1)
One week following catheter implantation animals were
allowed to nose poke to self-administer cocaine using a
fixed-ratio 1 (FR1) schedule of reinforcement (that is,
one nose poke in the active hole resulted in receipt of
one intravenous infusion of cocaine) for 3 hours daily
for 5 days at a cocaine dose of 0.5 mg/kg/infusion with
a maximum of 15 infusions possible per day. At the
start of the test a house light was turned on, indicating
drug availability. During FR1 testing, each active hole
nose poke resulted in a 50-μL infusion of cocaine HCl
delivered over 2.8 seconds accompanied by a stimulus
light in the active hole. Each infusion during this por-
tion of the test was followed by a 5-second timeout per-
iod, during which time nose pokes were recorded but
had no consequences. The dose (0.5 mg/kg/infusion)
was chosen because it is one that has been shown to
result in fairly rapid acquisition of the drug-taking beha-
vior [23]. Twelve animals began the experiment in each
treatment group. Animals that reached the criteria of 15
infusions on the FR1 schedule were moved to the FR2
schedule (two active hole nose pokes resulted in one
infusion). Only animals that achieved 15 infusions on
the FR2 schedule continued to the PR schedule. The
total number of animals to complete the study com-
prised 11 bHR females, 9 bLR females, 8 bHR males and
5 bLR males. Animals that failed to acquire self-admin-
istration behavior (that is, those that did not receive 15
infusions on the FR1 and FR2 schedules, comprising
two bLR females, one bHR male and five bLR males) or
animals that lost patency during the experiment (one
bHR female, one bLR female, three bHR males and two
bLR males) were removed from the study. The low
number of bLR males acquiring drug-taking behavior is
in agreement with our previously published data [5].
Progressive ratio testing (weeks 2 to 4)
Animals had 2 days off and then began daily cocaine
self-administration sessions on a PR schedule for
5 days/week for 3 weeks using cocaine doses of 0.3 mg/
kg/infusion, 0.4 mg/kg/infusion and 0.5 mg/kg/infusion,
respectively. While the dose range was narrow, signifi-
cantly different effects have been found with respect to
drug taking [24,26]. Each dose was given for 1 week,
and doses were counterbalanced among animals and
across groups using a Latin square design. We utilized a
6-hour PR schedule of reinforcement that escalated
through an exponential series, namely, 1, 3, 6, 9, 12, 17,
24, 32, 42, 56, 73, 95, 124, 161, 208 required nose pokes
per infusion and so on, adapted from Richardson and
Roberts [30]. A higher breaking point (BP) is an indica-
tion that the animal is more motivated to get the
cocaine, as they are willing to work harder to obtain an
infusion of the drug. The number of infusions, nose
pokes in the active hole, nose pokes in the inactive hole
and last completed ratio within 1 hour of the last infu-
sion (BP) were recorded. The session terminated after
6 hours or if 1 hour elapsed without an infusion.
Experiment 2: cocaine self-administration protocol
Fixed ratio training (week 1 and days 1 and 2 of week 2)
One week following catheter implantation animals were
allowed to nose poke to self-administer cocaine using
the FR1 and FR2 schedules for 3 hours daily for 7 days
(5 days on, 2 days off, 2 days on) at a cocaine dose of
0.4 mg/kg/infusion with the maximum number of infu-
sions possible being 15. Animals that reached the cri-
teria of 15 infusions on the FR1 schedule were moved
to the FR2 schedule. Animals remained on the FR2
schedule until PR training and were moved to the next
phase of the experiment only if they achieved 15 infu-
sions on the FR2 schedule. After excluding animals that
did not acquire the behavior (one bHR male and two
bLR males) or those that had catheters that were not
patent (one bHR female, two bLR females, two bHR
males and two bLR males), the final group numbers
were 11 bHR females, 10 bLR females, 9 bHR males and
8 bLR males.
Progressive ratio training (days 3 to 5 of week 2)
Animals were then given 3 days of experience on the PR
schedule at a cocaine dose of 0.4 mg/kg/infusion.
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We used the same PR schedule used in Experiment 1.
The number of infusions, nose pokes in the active hole,
nose pokes in the inactive hole and last completed ratio
within 1 hour (BP) were noted.
Progressive ratio testing (weeks 3 to 5)
Animals had 2 days off and then began daily cocaine
self-administration sessions on a PR schedule of 5 days/
week for 3 weeks using cocaine doses of 0.25 mg/kg/
infusion, 0.5 mg/kg/infusion and 0.75 mg/kg/infusion,
respectively. Each dose was given for 1 week, and doses
were counterbalanced as described above using the
same procedures described for Experiment 1.
Fixed ratio 5 (week 6)
For 4 days animals were put on an FR5 schedule for two
40-minute periods per day (separated by a 15-minute
drug nonavailability period) during which they could
self-administer cocaine (0.4 mg/kg/infusion) on a FR5
schedule (each infusion was followed by a 40-second
timeout) with a maximum of 50 infusions/period
(11 bHR females, 8 bLR females, 9 bHR males and 5
bLR males; numbers were reduced compared to week
2 because of loss of patency). Drug availability was sig-
naled by illumination of the house light, which was
turned off when the drug was unavailable. The second
FR5 drug availability session was used to prevent extinc-
tion of the drug-taking behavior. The number of infu-
sions and the number of active and inactive pokes
(during drug-available and nonavailable sessions) were
recorded, as well as the number of inefficient pokes
(pokes during the 40-second timeout), which did not
count toward receiving an infusion.
Statistics
Statistical analyses were performed using PASW Statis-
tics 18.0 software (SPSS, Inc., Somers, NY, USA). FR1,
FR2 and PR data were analyzed using repeated-measures
analysis of variance (ANOVA) with dose and day as
within-subject variables and phenotype (bLR or bHR)
and sex (male or female) as between-subject variables,
followed by a Bonferroni correction post hoc test when
applicable. Data obtained with the FR5 reinforcement
paradigm were analyzed separately for the drug avail-
ability and nonavailability periods using repeated-
measures ANOVA with day as the within-subject
variable and phenotype and sex as between-subject
variables, followed by a Bonferroni correction post hoc
test when applicable. For the drug-available sessions, the
number of nose pokes in the active and inactive holes,
number of infusions and number of ineffective nose
pokes in the active hole were analyzed. For the 15-min-
ute no-drug session, the number of nose pokes in the
previously active and inactive holes was analyzed. The
percentage changes in poking rates (nose pokes per
minute) between the first drug session and the following
no-drug period were calculated. Sphericity assumed
modeling with Greenhouse-Geisser and Huynh-Feldt
adjustments was applied [31].
Results
Experiment 1
Total number of infusions during acquisition
Phenotype significantly affected the total number of
infusions during the acquisition phase (F1,29 = 25.481,
P < 0.001). Post hoc analysis showed that bHR males
and females had a greater number of infusions during
the FR1 and FR2 schedules than their bLR counterparts
(F1,29 = 11.730, P = 0.001, and F1,29 = 11.730, P = 0.002,
respectively; data not shown). Greater cocaine intake
prior to the PR schedule did not enhance the BP; in
fact, the only correlation identified was for bHR females,
in which greater cocaine intake during acquisition was
negatively correlated with the BP at the 0.5 mg/kg/infu-
sion dose (r = -0.719, P = 0.013).
Impact of bHR-bLR phenotype and sex on breaking point
When animals were tested using a PR schedule of rein-
forcement to determine the BP for cocaine self-adminis-
tration, there were significant main effects of phenotype
(bHR > bLR, F1,29 = 43.475; P < 0.001), sex (female >
male, F1,29 = 6.720; P = 0.015) and dose (F2,59 = 5.301,
P = 0.008) (see Figure 1). Post hoc analyses were con-
ducted to examine the effect of phenotype within sex
and dose, and we found that bHR males had higher BPs
than bLR males at all doses (low to high dose: P =
0.003, P < 0.001, P = 0.001), and bHR females had
higher BPs than bLR females at all three doses (low to
high dose: P = 0.001, P < 0.001, P < 0.001). Post hoc
Figure 1 Breaking points (BPs) on a progressive ratio (PR)
schedule of reinforcement for bred High Responder (bHR) and
bred Low Responder (bLR) males and females at three
different doses of cocaine (Experiment 1). *P < 0.05, significant
effect of phenotype within sex at that dose; $P < 0.05, significant
effect of sex within phenotype at that dose.
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analyses also revealed that within dose and phenotype,
bLR females had higher BPs than bLR males at the
0.4 mg/kg/infusion dose (P = 0.05). While a main effect
of cocaine dose on BP was also found (F2,59 = 5.301, P =
0.008), post hoc analyses indicated that the dose effect
was only significant for the bHR females with the BP
being higher at the highest dose of cocaine (0.5 mg/kg/
infusion) compared with the lowest dose of cocaine
(0.3 mg/kg/infusion) (P = 0.012).
Experiment 2
Total number of infusions during acquisition of cocaine
self-administration
Phenotype significantly affected cocaine intake during
acquisition (F1,37 = 6.304, P = 0.017), with bHR males
administering a greater number of infusions during FR1
and FR2 than their bLR counterparts (F1,37 = 5.385, P =
0.026). The effect was not significant in females (data
not shown). BP was not correlated with the number of
infusions during FR1 and FR2 for any of the groups at
any of the cocaine doses (data not shown).
Impact of bHR-bLR phenotype and sex on breaking point
using an expanded dose range
When the dose range for BP was expanded compared
with Experiment 1, there were no significant main
effects, but there were significant interaction effects for
day and sex (F4,132 = 4.213, P = 0.003); day, sex and
phenotype (F4,132 = 2.614, P = 0.038); and dose and day
(F8,264 = 3.371, P = 0.012). Post hoc analyses indicated
that at 0.25 mg/kg/infusion and 0.5 mg/kg/infusion,
bHR females had a higher BP than bLR females (P =
0.015 and P = 0.044, respectively), and at 0.5 mg/kg/
infusion, bHR males had a higher BP than bLR males
(P = 0.026) (see Figure 2). bLR females showed a signifi-
cant increase in BP between the 0.25 and 0.75 mg/kg/
infusion doses (P < 0.005) and between the 0.5 and
0.75 mg/kg/infusion doses (P < 0.005). bHR females
demonstrated increased BP between the 0.5 and
0.75 mg/kg/infusion doses (P < 0.05). bHR males
showed a significant increase in BP between the 0.25
and 0.75 mg/kg/infusion doses (P < 0.05) (see Figure 2).
Thus, BP was highest at the 0.75 mg/kg/infusion dose
for all groups except the bLR males, which failed to
show an increase in BP relative to the two lower doses.
Impact of bHR-bLR phenotype and sex differences on
responding on an FR5 schedule of reinforcement and
during periods with no reinforcement
Animals were tested in two 40-minute drug-available
sessions (a FR5 schedule with a 40-second timeout after
infusions) that were separated by one 15-minute no-
drug period (when responses in the holes were recorded
but not reinforced). A significant effect of sex was found
on cocaine intake (F1,28 = 5.940, P = 0.021), with female
rats, regardless of phenotype, self-administering a
greater number of cocaine infusions than males (see
Figure 3). This greater drug intake was driven primarily
by higher cocaine intake by bHR females compared with
bHR males on the second day of testing (P = 0.02), with
a similar trend observed on the first day (P = 0.06).
A significant main effect of sex was found for the
total number of nose pokes in the active hole (F1,28 =
6.023, P = 0.021) during the drug-available session
during the FR5 sessions (see Figure 4). bLR females
demonstrated more active nose pokes than bLR males
Figure 2 BPs on a PR schedule of reinforcement for bHR and
bLR males and females using an expanded range of doses of
cocaine (Experiment 2). *P < 0.05, significant effect of phenotype
within sex at that dose. #P < 0.05, statistically significantly different
from the lowest dose (#1) or the middle dose (#2) within sex and
phenotype.
Figure 3 The number of infusions self-administered during the
40-minute drug-available sessions using a fixed ratio 5
schedule of reinforcement. $P < 0.05, significant effect of sex
within phenotype for that day. Closed squares, bHR males; closed
triangles, bHR females; open squares, bLR males; open triangles, bLR
females.
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on day 1 (P = 0.039), and bHR females demonstrated
more active nose pokes than bHR males on day 2 (P =
0.041). A significant main effect of sex was also found
for the number of ineffective nose pokes (nose pokes
during the 40-second timeout after each infusion) in
the active hole (F1,28 = 6.381, P = 0.017), with bLR
females poking more ineffectively on day 1 (P = 0.042)
and day 4 (P = 0.039).
The number of nose pokes in the active hole during
the 15-minute no-drug periods between the FR5 drug-
available sessions showed significant interaction effects
between day, sex and phenotype (F3,269 = 4.420, P =
0.008) (see Figure 5). On days 1 and 2, bLR females
demonstrated more pokes in the active hole during the
15-minute no-drug period compared with bHR females
(F1,23 = 5.413, P = 0.029, and F1,23 = 4.754, P = 0.040,
respectively). Additionally, bLR females poked signifi-
cantly less often in the active hole during this no-drug
period on day 4 compared with days 1 and 2 (P < 0.01).
Percentage change in active hole nose pokes
There was a significant interaction between sex and
phenotype on the change in poking rates in the active
hole between the drug and no-drug sessions (F1,27 =
5.76, P = 0.028), and there was a sex, phenotype and
day interaction (F3,27 = 3.262, P = 0.032). As illustrated
in Table 1, on the first day of FR5, bLR females
increased their poking rate by an average of 300%
(F1,58 = 8.923, P = 0.004) during the no-drug session
compared with the drug-available session (that is, com-
pared to 100%) bLR females also showed a significantly
greater percentage change in poking rates than
bLR males (F1,27 = 7.013, P = 0.013) and bHR females
(F1,27 = 9.647, P = 0.004). This increase in poking rate
in the active hole decreased during subsequent days
(day 1 vs. day 3, P = 0.03; day 1 vs. day 4, P = 0.005),
with poking rate significantly decreasing to 20% of the
drug-available session on day 4 (F1,58 = 4.395, P = 0.04).
On day 2, bLR females still had a higher percentage
change than their bHR counterparts (F1,27 = 6.966, P =
0.014). The other groups showed no change in poking
rates between the drug and no-drug sessions.
We did not identify any significant effects of estrous
cycle on any behaviors measured for either phenotype
(data not shown). In Experiments 1 and 2, 15 of 20 and
14 of 19 of the females, respectively, exhibited regular
estrous cycles for the duration of the study.
Discussion
In the present experiments, we investigated sex differ-
ences and the effect of selective breeding for novelty
reactivity on the motivation to self-administer cocaine
and for responding in the absence of reinforcement. We
report that bHR males and females exhibited higher
motivation to self-administer cocaine compared with
bLR rats. There is also an underlying sex difference in
the motivation to self-administer cocaine regardless of
phenotype, with females showing greater motivation
than males. Motivation for cocaine increased with dose,
so that all animals except bLR males demonstrated
significantly greater BPs at the highest dose tested
(0.75 mg/kg/infusion) compared with lower doses. Thus,
motivation contributes to the increased cocaine-taking
seen in bHR females and is likely affected by both sex
and phenotype.
Figure 4 The total number of nose pokes in the active hole
during the drug-available sessions separated by effective nose
pokes (those that count toward an infusion of cocaine) and
ineffective nose pokes (nose pokes during the 40-second
timeout). $P < 0.05, significant effect of sex within phenotype for
that day for total active pokes ($t) and ineffective active pokes ($i).
Figure 5 The number of nose pokes in the active hole during
the 15-minute no-drug period, at which time pokes were not
reinforced. *P < 0.05, significant effect of phenotype within sex for
that day. #P < 0.05, statistically significantly different from day 1 (#1)
or day 2 (#2) for bLR females. Closed squares, bHR males; closed
triangles, bHR females; open squares, bLR males; open triangles, bLR
females.
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Impact of the bHR-bLR phenotype on motivation for
cocaine
Prior research conducted at our laboratory demon-
strated that bHR males and females acquire cocaine
self-administration behavior significantly faster than bLR
males and females, and bHR female rats self-administer
greater amounts of cocaine than bHR males and bLR
males and females [5]. The current study aimed to
determine whether the higher drug intake previously
seen in bHR females is due to higher motivation for the
drug. We found that, in general, bHR rats exhibited
higher BPs than bLR rats, indicating an increased moti-
vation to take cocaine in the bHR versus bLR animals.
The mesolimbic dopamine system, specifically dopa-
minergic projections from the ventral tegmental area
(VTA) to the nucleus accumbens (NAc), has been stu-
died extensively for its role in mediating the rewarding
effects of drugs of abuse and may be responsible for
mediating the differences in motivation seen in the bHR
and bLR animals. Indeed, bHR and bLR animals exhibit
differences in their dopaminergic system, with bHR ani-
mals exhibiting differences in dopamine (DA) receptors
and sensitivity [12]. Studies conducted with outbred HR
and LR animals have shown similar findings, with HR
animals exhibiting increased responsivity to DA [32-34],
higher basal DA levels in the NAc [32] and more persis-
tent elevation in DA cell firing in the VTA compared
with LR animals [35], a neuroadaptation that appears to
be critical for the development of addictive behaviors
[36,37]. These differences in the dopaminergic reward
system may play a role in the enhanced motivation for
cocaine that we see in bHR animals.
Normally, within the dose range used in this study,
the amount of cocaine administered increases with dose
[24]. Interestingly, bLR males did not exhibit amplified
motivation to take cocaine at the highest dose, in con-
trast to significant increases in motivation demonstrated
by the other groups, including bLR females. It appears
that while the bLR phenotype is “protective” to a certain
degree by reducing the motivation for cocaine, this pro-
tection is limited in females, and ultimately sex over-
rides behavioral phenotype in this situation, resulting in
increased response for cocaine at a high dose (0.75 mg/
kg/infusion).
The level of motivation to self-administer cocaine
can be influenced by prior cocaine intake during self-
administration training (for review, see [38]). For
example, a level of 20 mg/kg/day during initial expo-
sure results in an escalation of subsequent BPs,
whereas an intake of 60 or even 100 mg/kg/day results
in stable responding on a PR schedule [39]. In the
experiments presented here, the 5- and 7-day FR
“training” period that preceded PR testing resulted in
bHR rats’ receiving more cocaine than bLR rats, which
could have affected the animals’ motivation for cocaine
and subsequent BPs. However, the intake differences in
the current study were significantly less than those
reported by Morgan et al. [39], where they resulted in
significant differences in BP, with intake differences
remaining within 3 mg/kg/day.
Impact of sex on motivation for cocaine
Females, in addition to acquiring cocaine self-adminis-
tration faster [5], also have higher motivation than
males to take cocaine. Thus, females may be more sensi-
tive than males to the reinforcing effects of cocaine.
These data confirm results in other reports that females
are willing to work harder than males for the same dose
of cocaine [22,25,40].
While females generally exhibit higher motivation for
cocaine than males, all differences in motivation to self-
administer cocaine were obscured at the highest dose
(0.75 mg/kg/infusion). This finding is similar to what we
have seen before, in that drug-taking differences are
often exhibited only at lower cocaine doses [23]. Moti-
vation to self-administer cocaine often increases with
escalating doses; thus, drug-taking differences are often
obscured when high cocaine doses are administered, as
all animals tend to exhibit elevated motivation for the
drug at higher doses. It is often only at the lowest doses
that subtle but significant differences emerge [23,26].
It is interesting to note, however, that while the bLR
females demonstrated a significant increase in motiva-
tion to self-administer cocaine at the highest dose, the
bLR males did not. It is possible that the bLR females
are more responsive than bLR males to the effects of
cocaine. The effect of sex on motivation for cocaine
may override the bLR phenotype at higher doses for the
Table 1 Change in the number of active nose pokes per minute between the first drug-available and no-drug sessions
expressed as percentage changes from the drug-available sessiona
Rat type Day 1 Day 2 Day 3 Day 4
bHR male 112.82 (33.0) 131.70 (33.3) 109.43 (46.5) 83.08 (46.4)
bHR female 72.17 (24.2) 59.54 (16.6) 60.77 (9.24) 82.00 (34.8)
bLR male 46.30 (24.5) 87.53 (10.3) 100.98 (46.7) 83.62 (51.8)
bLR female 290.85 (102.0)b,c,d 142.93 (37.5)c 88.03 (33.1)e 21.39 (5.0)e
abHR, bred High Responder; bLR, bred Low Responder; data are expressed as means ± SEM; bP < 0.05, effect of sex within phenotype for that day; cP < 0.05,
significantly different from 100%, P < 0.05; dP < 0.05, effect of phenotype within sex for that day; eP < 0.05, significantly different from Day 1.
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females, resulting in increased motivation for cocaine
compared with bLR males.
Neurobiological differences between LR and HR and
between bHR and bLR rats have been described for
male rats; however, several of the brain regions where
differences have been found are known to be sensitive
to estradiol in females. For example, bHR males have a
greater proportion of dopamine D2 (high) receptors in
the striatum [12], and our laboratory has shown that
dopamine release in the striatum is augmented by estra-
diol in females [41]. In addition, corticotropin-releasing
hormone (CRH) mRNA levels in the hypothalamic para-
ventricular nucleus (PVN) are lower in LR rats [11].
Estrogen receptors affect activation of CRH neurons in
the PVN [42], and estradiol in the PVN also modulates
the responsivity of the stress axis [43]. It is possible,
therefore, that estradiol in the bLR females augments
the rewarding effect of cocaine, but only at higher doses.
On the other hand, it is also possible that the brains
of the bLR males are simply less responsive to the
effects of the cocaine. Indeed, Flagel et al. [12] found
differences in dopaminergic circuitry in bLR males com-
pared with bHR males, and we have seen that bLR
males do not exhibit as robust a behavioral response to
cocaine sensitization as do bHR males [44].
Gonadal hormones have been shown to play a signif-
icant role in the sex differences that exist with regard
to drug-taking behavior [21,22,25]. We did not, how-
ever, find an effect of estrous cycle on the motivation
to take cocaine in the experiments presented here,
even though the majority of females continued to exhi-
bit regular estrous cycles for the duration of the
experiment. We previously reported a similar lack of
effect of the estrous cycle on the acquisition of
cocaine-taking behavior [5], which is likely due to the
large number of females that exhibited aberrant cycles
or stopped cycling altogether as a result of cocaine
exposure. Lynch et al. [27] also reported irregular
estrous cycles during cocaine self-administration in
female rats. It is important to note that the previous
studies reporting the effects of endogenous estrous
cycles on BPs differed from ours in a number of ways
[25]. For example, the animals in previous studies were
reinforced with a much higher cocaine dose during
self-administration training and PR testing (0.6 mg/
infusion) than the dose that we used. The animals in
the other studies also self-administered cocaine for a
shorter period and were housed in self-administration
boxes for the duration of the study. These are impor-
tant methodological differences that could potentially
affect the results.
Additionally, our finding of a lack of effect of the
estrous cycle may be due, at least in part, to the varia-
tion in circulating hormone levels between females at
the time of testing. We have previously seen clear
effects of estradiol on cocaine self-administration when
administered to OVX females [23,26]. In these prior
studies, however, the time of behavioral testing
was tightly regulated with regard to the exogenously
administered hormone. Variation between females in
circulating hormone levels at the time of testing, inde-
pendent of lavage readings, could add to the variation
seen in motivation, which could obscure differences
that would otherwise be identified during post hoc
analysis.
Thus, the sex differences in cocaine self-administra-
tion may be exacerbated by, but do not appear to
require, high levels of circulating gonadal hormones.
Indeed, we have shown previously that OVX females
that were not given estradiol replacement exhibited
higher levels of self-administration than males, confirm-
ing that circulating hormones are not necessary to
maintain a female’s increased drug abuse liability [26].
Impact of phenotype and sex on continuing to response
without reinforcement
In recent years, researchers have been attempting to
more closely model human addiction by adding tests
based on the criteria in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition [45], for
substance dependence, such as persisting to respond to
a drug in the absence of reinforcement or in the pre-
sence of a punishment [6,46]. Animals that are unable
to refrain from responding when the drug is not
received are said to demonstrate increased drug-seeking,
a marker of addiction.
Thus, in Experiment 2, we added a test to examine
the continuation of responding in the absence of rein-
forcement. During the first two 15-minute drug-free
sessions, bLR females responded significantly more
often than the bLR males; there were no differences
between the bHR groups. To compare rates of
responding during the drug-free and drug-available
sessions, we calculated the number of pokes per min-
ute during the 15-minute drug-free session and
expressed that number as a percentage change from
the poking rate during the drug-available session. In
this part of the experiment, it was clear that the bLR
females exhibited a significant increase in rates of
responding during the non-reinforced (that is, drug-
free) period compared with the period when the drug
was available. According to these data, the bLR females
demonstrated increased drug-seeking in the absence of
reinforcement. However, analysis of the poking rate on
subsequent days demonstrated that the bLR females
were the only group that changed its rate of poking
during the drug-free period in successive sessions and
actually decreased its rates of responding during
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periods of no reinforcement on subsequent days. This
change in poking rate was specific for the drug-free
period, since poking rate during the drug-available ses-
sion did not change. Interestingly, the other groups
continued to respond at about the same rate as during
the preceding drug-available period, showing no sign
of learning that nose poking was not being reinforced
during the drug-free session.
Summary and conclusion
The experiments presented here are the first to evaluate
how the selectively bred, novelty-seeking phenotype as
well as the sex of an individual affect motivation to self-
administer cocaine. An individual’s sex continues to
increase drug abuse liability. We found underlying sex
differences in motivation to take cocaine, with females
having higher BPs than males, regardless of phenotype,
demonstrating that these factors are dissociable. Addi-
tionally, reactivity to novelty affected motivation to take
cocaine, as bHR animals had higher BPs than bLR ani-
mals at most of the doses tested. At the highest dose
(0.75 mg/kg/infusion), all phenotype and sex differences
disappeared, as all groups (except for bLR males)
demonstrated significantly higher BPs than they did at
the lower doses.
Acknowledgements
This study was funded by grants from the National Institutes of Drug Abuse
to JBB (R01 DA12677) and HA (PPG 5P01DA021633-02) and the Office of
Naval Research grant N00014-02-1-0879 to HA. Support for JAC was
provided by the Reproductive Sciences Training Grant (T32 HD07048). We
thank Brandon Luma and Melissa Luma for their technical assistance with
these experiments and Shelly Flagel for her helpful review of the
manuscript.
Author details
1Molecular and Behavioral Neuroscience Institute, University of Michigan,
Ann Arbor, MI 48109, USA. 2Department of Psychiatry, University of
Michigan, Ann Arbor, MI 48109, USA. 3Department of Psychology, University
of Michigan, Ann Arbor, MI 48109, USA. 4Office of Research and Grants, Ohio
University College of Osteopathic Medicine, Athens, OH 45701, USA.
Authors’ contributions
JC participated in the design of the experiment, acquired all data, assisted in
the input of data for analysis, participated in the interpretation of the data
and drafted the manuscript. BG participated in the design of the
experiment, assisted in gathering and inputting the data for analysis and
assisted with the editing the manuscript. CW assisted in the input of data
for analysis, conducted statistical analyses and assisted in the drafting of the
manuscript. SC prepared and coordinated selectively bred animals prior to
the experimental procedures and assisted in the editing of the manuscript.
HA conceived of the bHR/bLR lines and contributed to the editing of the
manuscript. JB conceived of the project, participated in its design and
assisted in drafting and editing the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 October 2010 Accepted: 11 March 2011
Published: 11 March 2011
References
1. S Dawe, NJ Loxton, The role of impulsivity in the development of
substance use and eating disorders. Neurosci. Biobehav. Rev. 28, 343–351
(2004). doi:10.1016/j.neubiorev.2004.03.007
2. CR Cloninger, A systematic method for clinical description and classification
of personality variants: a proposal. Arch. Gen. Psychiatry 44, 573–588 (1987)
3. JL Perry, ME Carrol, The role of impulsive behavior in drug abuse.
Psychopharmacology 200, 1–26 (2008). doi:10.1007/s00213-008-1173-0
4. M Zuckerman, M Neeb, Sensation seeking and psychopathology. Psychiatry
Res. 1, 255–264 (1979). doi:10.1016/0165-1781(79)90007-6
5. BA Davis, SM Clinton, H Akil, JB Becker, The effects of novelty-seeking
phenotypes and sex differences on acquisition of cocaine self-
administration in selectively bred High-Responder and Low-Responder rats.
Pharmacol. Biochem. Behav. 90, 331–338 (2008). doi:10.1016/j.
pbb.2008.03.008
6. D Belin, AC Mar, JW Dalley, TW Robbins, BJ Everitt, High impulsivity predicts
the switch to compulsive cocaine-taking. Science 320, 1352–1355 (2008).
doi:10.1126/science.1158136
7. PV Piazza, JM Deminière, M Le Moal, H Simon, Factors that predict
individual vulnerability to amphetamine self-administration. Science 245,
1511–1513 (1989). doi:10.1126/science.2781295
8. PV Piazza, S Maccari, JM Deminière, M Le Moal, P Mormede, H Simon,
Corticosterone levels determine individual vulnerability to amphetamine
self-administration. Proc. Natl. Acad. Sci. USA 88, 2088–2092 (1991).
doi:10.1073/pnas.88.6.2088
9. PV Piazza, JM Deminière, S Maccari, M Le Moal, P Mormède, H Simon,
Individual vulnerability to drug self-administration: action of corticosterone
on dopaminergic systems as a possible pathophysiological mechanism. in
The Mesolimbic Dopamine System: From Motivation to Action, ed. by P
Willner, J Scheel-Krüger (John Wiley & Sons Ltd, New York, 1991), pp.
473–495
10. JD Stead, S Clinton, C Neal, J Schneider, A Jama, S Miller, DM Vazquez, SJ
Watson, H Akil, Selective breeding for divergence in novelty-seeking traits:
heritability and enrichment in spontaneous anxiety-related behaviors.
Behav. Genet. 36, 697–712 (2006). doi:10.1007/s10519-006-9058-7
11. M Kabbaj, DP Devine, VR Savage, H Akil, Neurobiological correlates of
individual differences in novelty-seeking behavior in the rat: differential
expression of stress-related molecules. J. Neurosci. 20, 6983–6988 (2000)
12. SB Flagel, TE Robinson, JJ Clark, SM Clinton, SJ Watson, P Seeman, PE
Phillips, H Akil, An animal model of genetic vulnerability to behavioral
disinhibition and responsiveness to reward-related cues: implications for
addiction. Neuropsychopharmacology 35, 388–400 (2010). doi:10.1038/
npp.2009.142
13. S Clinton, S Miller, SJ Watson, H Akil, Prenatal stress does not alter innate
novelty-seeking behavioral traits, but differentially affects individual
differences in neuroendocrine stress responsivity.
Psychoneuroendocrinology 33, 162–177 (2008). doi:10.1016/j.
psyneuen.2007.10.012
14. WJ Lynch, ME Roth, ME Carroll, Biological basis of sex differences in drug
abuse: preclinical and clinical studies. Psychopharmacology (Berl) 164,
121–137 (2002). doi:10.1007/s00213-002-1183-2
15. SJ Robbins, RN Ehrman, AR Childress, CP O’Brien, Comparing levels of
cocaine cue reactivity in male and female outpatients. Drug Alcohol
Depend. 53, 223–230 (1999). doi:10.1016/S0376-8716(98)00135-5
16. M Sofuoglu, S Dudish-Poulsen, D Nelson, PR Pentel, DK Hatsukami, Sex and
menstrual cycle differences in the subjective effects from smoked cocaine
in humans. Exp. Clin. Psychopharmacol. 7, 274–283 (1999). doi:10.1037/
1064-1297.7.3.274
17. SM Evans, M Haney, RW Foltin, The effects of smoked cocaine during the
follicular and luteal phases of the menstrual cycle in women.
Psychopharmacology 159, 397–406 (2002). doi:10.1007/s00213-001-0944-7
18. SD Glick, PA Hinds, Sex differences in sensitization to cocaine-induced
rotation. Eur. J. Pharmacol. 99, 119–121 (1984). doi:10.1016/0014-2999(84)
90442-4
19. M Hu, JB Becker, Effects of sex and estrogen on behavioral sensitization to
cocaine in rats. J. Neurosci. 23, 693–699 (2003)
20. WJ Lynch, ME Carroll, Sex differences in the acquisition of intravenously
self-administered cocaine and heroin in rats. Psychopharmacology 144,
77–82 (1999). doi:10.1007/s002130050979
21. WJ Lynch, ME Roth, JL Mickelberg, ME Carroll, Role of estrogen in the
acquisition of intravenously self-administered cocaine in female rats.
Cummings et al. Biology of Sex Differences 2011, 2:3
http://www.bsd-journal.com/content/2/1/3
Page 9 of 10
Pharmacol. Biochem. Behav. 68, 641–646 (2001). doi:10.1016/S0091-3057(01)
00455-5
22. ME Carroll, AD Morgan, WJ Lynch, UC Campbell, NK Dess, Intravenous
cocaine and heroin self-administration in rats selectively bred for differential
saccharin intake: phenotype and sex differences. Psychopharmacology (Berl)
161, 304–313 (2002). doi:10.1007/s00213-002-1030-5
23. M Hu, HS Crombag, TE Robinson, JB Becker, Biological basis of sex
differences in the propensity to self-administer cocaine.
Neuropsychopharmacology 29, 81–85 (2004). doi:10.1038/sj.npp.1300301
24. M Hu, JB Becker, Acquisition of cocaine self-administration in
ovariectomized female rats: effect of estradiol dose or chronic estradiol
administration. Drug Alcohol Depend. 94, 56–62 (2008). doi:10.1016/j.
drugalcdep.2007.10.005
25. DCS Roberts, SAL Bennett, GJ Vickers, The estrous cycle affects cocaine self-
administration on a progressive ratio schedule in rats. Psychopharmacology
98, 408–411 (1989). doi:10.1007/BF00451696
26. JB Becker, M Hu, Sex differences in drug abuse. Front Neuroendocrinol. 29,
36–47 (2008). doi:10.1016/j.yfrne.2007.07.003
27. WJ Lynch, MN Arizzi, ME Carroll, Effects of sex and the estrous cycle on
regulation of intravenously self-administered cocaine in rats.
Psychopharmacology 152, 132–139 (2000). doi:10.1007/s002130000488
28. JB Becker, KJ Berkley, N Geary, E Hampson, JP Herman, EA Young, Sex
Differences in the Brain: From Genes to Behavior. (Oxford University Press,
New York, 2008)
29. HS Crombag, A Badiani, S Maren, TE Robinson, The role of contextual
versus discrete drug-associated cues in promoting the induction of
psychomotor sensitization to intravenous amphetamine. Behav. Brain Res.
116, 1–22 (2000). doi:10.1016/S0166-4328(00)00243-6
30. NR Richardson, DC Roberts, Progressive ratio schedules in drug self-
administration studies in rats: a method to evaluate reinforcing efficacy.
J. Neurosci. Methods 66, 1–11 (1996). doi:10.1016/0165-0270(95)00153-0
31. SM Quintana, SE Maxwell, A Monte-Carlo comparison of 7 epsilon-
adjustment procedures in repeated-measures designs with small sample
sizes. J. Educ. Stat. 19, 57–71 (1994). doi:10.2307/1165177
32. MS Hooks, AC Colvin, JL Juncos, JB Justice Jr, Individual differences in basal
and cocaine-stimulated extracellualr dopamine in the nucleus accumbens
using quantitative microdialysis. Brain Res. 587, 306–312 (1992). doi:10.1016/
0006-8993(92)91012-4
33. MS Hooks, JL Juncos, JB Justice Jr, SM Meiergerd, SL Povlock, JO Schenk,
PW Kalivas, Individual locomotor response to novelty predicts selective
alterations in D1 and D2 receptors and mRNAs. J. Neurosci. 14, 6144–6152
(1994)
34. MS Hooks, PW Kalivas, Involvement of dopamine and excitatory amino acid
transmission in novelty-induced motor activity. J. Pharmacol. Exp. Ther. 269,
976–988 (1994)
35. JE McCutcheon, FJ White, M Marinelli, Individual differences in dopamine
cell neuroadaptations following cocaine self-administration. Biol. Psychiatry
66, 801–803 (2009). doi:10.1016/j.biopsych.2009.04.018
36. ME Wolf, FJ White, XT Hu, MK-801 prevents alterations in the
mesoaccumbens dopamine system associated with behavioral sensitization
to amphetamine. J. Neurosci. 14, 1735–1745 (1994)
37. P Vezina, Sensitization of midbrain dopamine neuron reactivity and the self-
administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 27,
827–839 (2004). doi:10.1016/j.neubiorev.2003.11.001
38. DC Roberts, D Morgan, Y Liu, How to make a rat addicted to cocaine. Prog.
Neuropsychopharmacol. Biol. Psychiatry 31, 1614–1624 (2007). doi:10.1016/j.
pnpbp.2007.08.028
39. D Morgan, Y Liu, DC Roberts, Rapid and persistent sensitization to the
reinforcing effects of cocaine. Neuropsychopharmacology 31, 121–128
(2006). doi:10.1038/sj.npp.1300953
40. J Blount, W Lynch, Sex differences in motivation for cocaine as a function
of stage of addiction. Ethn. Dis. 19, S7–S8 (2009)
41. JB Becker, CN Rudick, Rapid effects of estrogen or progesterone on the
amphetamine-induced increase in striatal dopamine are enhanced by
estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 64,
53–57 (1999). doi:10.1016/S0091-3057(99)00091-X
42. S Thammacharoen, N Geary, TA Lutz, S Ogawa, L Asarian, Divergent effects
of estradiol and the estrogen receptor-α agonist PPT on eating and
activation of PVN CRH neurons in ovariectomized rats and mice. Brain Res.
1268, 88–96 (2009). doi:10.1016/j.brainres.2009.02.067
43. HF Figueiredo, YM Ulrich-Lai, DC Choi, JP Herman, Estrogen potentiates
adrenocortical responses to stress in female rats. Am. J. Physiol. Endocrinol.
Metab. 292, E1173–E1182 (2007). doi:10.1152/ajpendo.00102.2006
44. MJ García-Fuster, JA Perez, SM Clinton, SJ Watson, H Akil, Impact of cocaine
on adult hippocampal neurogenesis in an animal model of differential
propensity to drug abuse. Eur. J. Neurosci. 31, 79–89 (2010)
45. American Psychiatric Association, Diagnostic and Statistical Manual of Mental
Disorders, 4th edn. (American Psychiatric Association, Washington, DC, 1994)
46. V Deroche-Gamonet, D Belin, PV Piazza, Evidence for addiction-like behavior
in the rat. Science 305, 1014–1017 (2004). doi:10.1126/science.1099020
doi:10.1186/2042-6410-2-3
Cite this article as: Cummings et al.: Effects of a selectively bred
novelty-seeking phenotype on the motivation to take cocaine in male
and female rats. Biology of Sex Differences 2011 2:3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cummings et al. Biology of Sex Differences 2011, 2:3
http://www.bsd-journal.com/content/2/1/3
Page 10 of 10
